# OnCo record da-brexpiprazole (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/da-brexpiprazole/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "da-brexpiprazole" ;
  schema:name "Brexpiprazole"@en ;
  schema:description "Brexpiprazole has a US indication for agitation in Alzheimer’s dementia after other causes are considered. Antipsychotics increase mortality in elderly people with dementia-related psychosis."@en ;
  schema:url <https://onco.cc/drugs/da-brexpiprazole/> ;
  schema:dateModified "2026-09-21"^^xsd:date ;
  schema:citation <https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-treat-agitation-symptoms-associated-dementia-due-alzheimers-disease> ;
  onco:status "approved" ;
  onco:tag "dementia-atlas" ;
  onco:modality "small molecule" ;
  schema:alternateName "Rexulti" ;
  onco:approval "US 2023: Agitation associated with dementia due to Alzheimer’s disease" ;
  onco:cancers <https://onco.cc/diagnoses/alzheimers-disease/> .